Dexmedetomidine 1 μg/kg

PreclinicalSmall molecule

TThe Second Affiliated Hospital of Chongqing Medical University

Dexmedetomidine 1 μg/kg is one of 33 small molecule programs targeting Chronic Obstructive Pulmonary Disease. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Obstructive Pulmonary DiseaseActive, not recruiting

Loss of ConsciousnessActive, not recruiting

Chronic Obstructive Pulmonary DiseasePreclinical

Active, not recruiting

Loss of ConsciousnessPreclinical

Active, not recruiting

Competition

Competitive Landscape

557 competitors in Chronic Obstructive Pulmonary Disease

#DrugCompanyPhaseTrials

Aclidinium Bromide

AstraZeneca

Preclinical

21 2

Formoterol Fumarate

AstraZeneca

Preclinical

11 3

Calciferol

Alnylam Pharmaceuticals

Preclinical

—4

Proventil

Mylan Pharmaceuticals Inc

Preclinical

3 5

Duragesic

CCephalon

Preclinical

2 6

Narcan

SScienture

Preclinical

1 7

Zoloft

VViatris Specialty LLC

Preclinical

1 8

Versed

CConrado Roberto Hoffmann Filho

Antibiotic

1 10

Insulin Therapy

Sanofi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

Post-ApprovalNot yet recruiting

Magnetic Resonance Imaging

NCT07369128

Clinical

Trials by Indication[1]

Dexmedetomidine2 trials

The Anesthesia Effects of Dexmedetomidine Combined With Desflurane or Propofol in Lobectomy

Recruiting·TThe Second Affiliated Hospital of Chongqing Medical University·N/A·NCT06207344·120 enrolled

Dexmedetomidine in Pediatric Tonsillectomy

Completed·—·Phase 4·NCT01057381·109 enrolled

Loss of consciousness1 trial

The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial

Completed·GGeneral Hospital of Ningxia Medical University·N/A·NCT02783846·73 enrolled

Regional Anesthesia1 trial

Analgesic Efficacy of Two Doses of Dexmedetomidine as Adjuncts to Lidocaine for Intravenous Regional Anesthesia

Completed·—·Phase 4·NCT03399474·60 enrolled

Magnetic Resonance Imaging1 trial

Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

Not yet recruiting·—·Phase 4·NCT07369128·105 enrolled

External Oblique Intercostal Plane Block1 trial

Different Doses of Dexmedetomidine in External Oblique Intercostal Plane Block in Splenectomy

Completed·TTanta University·N/A·NCT06363578·50 enrolled

2 more indications

Chronic Obstructive Pulmonary Disease1 trial

Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease

Terminated·TThe Second Affiliated Hospital of Chongqing Medical University·N/A·NCT06207331·6 enrolled

Analgesia1 trial

A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block

Completed·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·Phase 2·NCT07249827·69 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Dexmedetomidine 1 μg/kg. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dexmedetomidine 1 μg/kg compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dexmedetomidine 1 μg/kg. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The Second Affiliated Hospital of Chongqing Medical University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TThe Second Affiliated Hospital of Chongqing Medical University

Dexmedetomidine 1 μg/kg

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

Dexmedetomidine2 trials

Loss of consciousness1 trial

Regional Anesthesia1 trial

Magnetic Resonance Imaging1 trial

External Oblique Intercostal Plane Block1 trial

Chronic Obstructive Pulmonary Disease1 trial

Analgesia1 trial

References

Drug Info

Quick Facts

Related News